Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
It is a non-randomized, open-label phase II treatment trial (single group assignment) evaluating CP101 in adults with Clostridioides difficile infection (CDI) (recurrent)
Number of Participants With Absence of Recurrence Through Week 8 Based on Adjudication, safety
No published results found as of June 2026
…